Overview
Status
Active
Registry date
2013-08-06
Share capital
10,000.00 PLN
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Financial insight
- The statement flags a going concern risk.
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 83 days late).
- 202514/07/2026
- 202412/07/2025
- 202307/07/2024
- 202231/03/2023
- 202106/10/2022
- 202014/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Adrian Franciszek Holek – Vice President of the Management Board
Andrzej Stanisław Woźnica – Vice President of the Management Board
Przemysław Tadeusz Ziemski – President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Adrian Franciszek Holekage 65 | 19 | $513.24 | 19% |
Czesław Jerzy Kliśage 76 | 19 | $513.24 | 19% |
Roman Zygmunt Mańkaage 72 | 19 | $513.24 | 19% |
Andrzej Stanisław Woźnicaage 63 | 24 | $648.30 | 24% |
Przemysław Tadeusz Ziemskiage 38 | 19 | $513.24 | 19% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Medical Algorithmssp. z o.o. | $682.08 | medicalalgorithms.eu | ||
| Aiventrosp. z o.o. | $0.00 | aiventro.com | ||
| BioencaS.A. | $0.00 | bioenca.pl | ||
| Codagenesp. z o.o. | – | codagene.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-01-12 | PKD change (Removed: 107 codes) | |
| 2014-11-17 | Address change (Bankowa 12, 40-007, Katowice → Poleska 26, 40-733, Katowice) | |
| 2013-08-06 | Entered in the register |
FAQ
The main business activity of Abtow Biotechnology focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 6, 2013.
The headquarters is located at: Poleska 26, 40-733 Katowice.
The management board consists of: Adrian Franciszek Holek (Vice President of the Management Board), Andrzej Stanisław Woźnica (Vice President of the Management Board), and Przemysław Tadeusz Ziemski (President of the Management Board).
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-07-17